Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

232
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
232
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

301
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
301
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

325
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
325
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.8K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.8K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

218
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
218
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

469
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
469

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation of a simplified modeling approach to predict strain in the cartilage and labrum of the hip with application to femoroacetabular impingement syndrome.

Journal of biomechanics·2026
Same author

Simulation of Transcatheter Therapies for Atrioventricular Valve Regurgitation in an Open-Source Finite Element Simulation Framework.

Annals of biomedical engineering·2026
Same author

Effects of bone deformation on patient-specific finite element predictions of hip chondrolabral mechanics.

Journal of the mechanical behavior of biomedical materials·2026
Same author

An open-source computational framework for immersed fluid-structure interaction modeling using FEBio and MFEM.

ArXiv·2026
Same author

Intrinsic Viscoelasticity of Type II Collagen Contributes to the Viscoelastic Response of Immature Bovine Articular Cartilage Under Unconfined Compression Stress Relaxation.

Journal of biomechanical engineering·2026
Same author

Effect of Right Ventricular Outflow Tract Material Properties on Simulated Transcatheter Pulmonary Placement.

ArXiv·2026

Related Experiment Video

Updated: Jan 6, 2026

Patient-specific Modeling of the Heart: Estimation of Ventricular Fiber Orientations
12:09

Patient-specific Modeling of the Heart: Estimation of Ventricular Fiber Orientations

Published on: January 8, 2013

14.0K

Theoretical Considerations for Patient-Specific Modeling Based on Observable State Variables.

Gerard A Ateshian1,2, Sarah Deiters3,2, Jeffrey A Weiss4

  • 1Department of Mechanical Engineering, Columbia University, New York, NY 10027; Department of Biomedical Engineering, Columbia University, New York, NY 10027.

Journal of Biomechanical Engineering
|September 23, 2025
PubMed
Summary
This summary is machine-generated.

Biomedical engineers cannot directly measure patient-specific tissue failure risk. Instead, establish in vitro correlations between observable imaging data and material properties for computational modeling.

More Related Videos

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
14:14

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

Published on: August 12, 2018

9.2K
Movement Retraining using Real-time Feedback of Performance
08:16

Movement Retraining using Real-time Feedback of Performance

Published on: January 17, 2013

13.7K

Related Experiment Videos

Last Updated: Jan 6, 2026

Patient-specific Modeling of the Heart: Estimation of Ventricular Fiber Orientations
12:09

Patient-specific Modeling of the Heart: Estimation of Ventricular Fiber Orientations

Published on: January 8, 2013

14.0K
Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
14:14

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

Published on: August 12, 2018

9.2K
Movement Retraining using Real-time Feedback of Performance
08:16

Movement Retraining using Real-time Feedback of Performance

Published on: January 17, 2013

13.7K

Area of Science:

  • Biomedical Engineering
  • Mechanics of Materials
  • Medical Imaging

Background:

  • Assessing patient-specific tissue failure risk is crucial for computational modeling.
  • Noninvasive imaging modalities are increasingly used to gather patient data.
  • Direct measurement of patient-specific material properties is theoretically limited.

Purpose of the Study:

  • To outline theoretical considerations for assessing patient-specific tissue failure risk using noninvasive imaging.
  • To guide biomedical engineers in developing patient-specific computational models.
  • To address the challenge of inferring unobservable material properties from observable data.

Main Methods:

  • Reviewing fundamental theoretical concepts in mechanics.
  • Identifying observable state variables measurable via noninvasive imaging (e.g., morphology, transport, composition).
  • Establishing in vitro correlations between material properties and observable variables.

Main Results:

  • Patient-specific material properties, like tissue failure risk, are not directly observable.
  • Observable state variables (e.g., tissue morphology) can be assessed noninvasively.
  • In vitro correlations are essential for linking observable data to material properties.

Conclusions:

  • Inferring patient-specific material properties requires establishing robust in vitro correlations.
  • The uncertainty in derived material properties is limited by the in vitro correlation's uncertainty.
  • Future work should focus on translating in vitro correlations to in vivo applications for accurate risk assessment.